Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL555852 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL6888416 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL10007983 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL887706 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL554611 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL483813 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL12491170 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| 1,6-Hexanediol SCHEMBL4564056 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL20680773 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL427921 | 1.00 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225822-B1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4554379-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | Apeo - Agronomical Plant Extracts & Essential Oils (BE) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024013148-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO – AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2024-01-18 | — | — | WO | disclosed |
| US-20230416446-A1 | Method for Producing Polyurethane Foams or Hydrogels by Employing Diol Containing Formulations | COVESTRO DEUTSCHLAND AG (DE) | 2023-12-28 | — | — | US | disclosed |
| CN-116981709-A | Method for producing polyurethane foam or hydrogel by using diol-containing formulation | 科思创德国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-4225822-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | Covestro Deutschland AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-3995522-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | Covestro LLC (US) | 2022-05-11 | — | — | EP | disclosed |
| WO-2022073835-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING AMINE CHAIN EXTENDERS | COVESTRO DEUTSCHLAND AG (DE) | 2022-04-14 | — | — | WO | disclosed |
| WO-2022073834-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2022-04-14 | — | — | WO | disclosed |
| EP-2686366-B1 | BIO-BASED POLYESTER LATEX | OCE TECH BV (NL) | 2019-12-25 | — | — | EP | disclosed |
| WO-2017100744-A1 | AMINOLIPIDOIDS AND USES THEREOF | Preceres Inc. (US) | 2017-06-15 | — | — | WO | disclosed |
| US-9079828-B2 | Polymerizable compounds comprising a polyalicylic structure element | VOCO GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9068091-B2 | Bio-based polyester latex | OCE TECHNOLOGIES B.V. (NL) | 2015-06-30 | — | — | US | disclosed |
| US-8697772-B2 | Polymerizable phosphoric acid derivatives comprising a polyalicylic structure element | VOCO GMBH (DE) | 2014-04-15 | — | — | US | disclosed |
| EP-2686366-A1 | BIO-BASED POLYESTER LATEX | OCE-Technologies B.V. (NL) | 2014-01-22 | — | — | EP | disclosed |
| CN-103403056-A | Bio-based polyester latex | OCE TECH BV | 2013-11-20 | — | — | CN | disclosed |
| WO-2012123267-A1 | BIO-BASED POLYESTER LATEX | OCE-TECHNOLOGIES B.V. (NL) | 2012-09-20 | — | — | WO | disclosed |
| US-20120115108-A1 | POLYMERIZABLE PHOSPHORIC ACID DERIVATIVES COMPRISING A POLYALICYLIC STRUCTURE ELEMENT | VOCO GMBH (DE) | 2012-05-10 | — | — | US | disclosed |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | PCBP1, PUF60, PARG | LMNA 387/4885ALDH1A1 3882/4885HSD17B10 4481/4885 |
| US-20120115108-A1 | POLYMERIZABLE PHOSPHORIC ACID DERIVATIVES COMPRISING A POLYALICYLIC STRUCTURE ELEMENT | CAD, PCBP1, PPIP5K2 | LMNA 1158/4885ALDH1A1 2866/4885HSD17B10 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.